MinuteClinic, American Heart Association target high BP
MinuteClinic has partnered with the American Heart Association to improve the identification, treatment and management of high blood pressure.
CDR
RxAlly’s new CIO has PharmD
Pharmacy alliance RxAlly has appointed Michael Groh as chief information officer. As CIO, Groh will oversee RxAlly’s technology and data initiatives, the company said Tuesday.
AmerisourceBergen lands pact with Express Scripts
AmerisourceBergen Corp. has entered a multiyear agreement to supply pharmaceuticals to Express Scripts Inc., which has opted to let its current distribution pact with Cardinal Health Inc. lapse. AmerisourceBergen said Tuesday that under the three-year deal, it will supply about $18.
Tre Milano obtains court order vs. Amazon
Tre Milano said a California court has ordered online retail giant Amazon to send notice to more than 20,000 consumers who may have bought counterfeit versions of the InStyler rotating hair iron.
Luden’s promotion seeks best jingle
Throat lozenges brand Luden’s is calling on online voters in its search for the best original jingle based on the theme, "Surprisingly Soothing, Simply Delicious!".
Unilever sells frozen meals business to ConAgra
Unilever has agreed to sell its North America frozen meals business to ConAgra Foods Inc. for $265 million. The companies said Monday that the cash deal is expected to close in the third quarter.
CVS readies flu shot voucher program
Next month CVS/pharmacy and MinuteClinic plan to launch a flu shot voucher program for people without health insurance. Parent company CVS Caremark Corp.
Paragon shareholders OK sale to Shoppers Drug Mart
Shareholders of Paragon Pharmacies Ltd. have given the green light to the western Canada drug chain’s sale to Shoppers Drug Mart Corp. Paragon said the $73.5 million (Canadian) deal was approved at the company’s shareholders meeting late last week in Winnipeg, Manitoba.
Supervalu ousts CEO Herkert
Struggling food and drug retailer Supervalu Inc. has named chairman Wayne Sales as chief executive officer, replacing Craig Herkert. Supervalu said Monday that Sales, 62, will continue to serve as chairman and that board member Philip Francis has been elected lead director.
McLane to buy foodservice wholesaler
McLane Co. plans to acquire Meadowbrook Meat Co. (MBM), a national foodservice distributor. Financial terms of the deal weren’t disclosed. McLane chief executive officer Grady Rosier stated Thursday that the acquisition expands McLane’s portfolio of companies in the food and beverage industries.
NABP flags illegal online drug sellers
A National Association of Boards of Pharmacy (NABP) examination of more than 10,000 websites selling prescription drugs found that 97% were operating out of compliance with U.S.
NACDS: Bill could coordinate federal action on Rx abuse
Pending legislation can help align the response of federal agencies to the rising problem of prescription drug abuse and drug diversion, according to the National Association of Chain Drug Stores. In a letter Thursday to Sen. Tom Harkin (D.
Pharmacist specialty certifications on the rise
Complex medication regimens and challenges in health care delivery are driving exponential growth in the demand for BPS board-certified pharmacists, according to the Board of Pharmacy Specialties (BPS).
Taro nixes Sun Pharma buyout bid
Taro Pharmaceutical Industries Ltd. has given a thumbs-down to an unsolicited buyout proposal by Sun Pharmaceutical Industries Ltd. Taro said Thursday that a special committee of its board unanimously rejected the Oct.
Jean Coutu Group board adds new member
The board of Jean Coutu Group has elected Cora Mussely Tsouflidou as a director. The Canadian drug chain said late Wednesday that Tsouflidou was voted onto the Jean Coutu Group board at the company’s recent shareholders meeting.
Sales climb in 2Q at Shoppers Drug Mart
Shoppers Drug Mart Corp. saw revenue and same-store sales edge up for its 2012 second quarter. The Canadian drug chain’s net earnings dipped in the second quarter versus a year ago, although earnings per share rose and were in line with the consensus estimate of financial analysts.